Veracyte, Inc. (VCYT) 의 후행 P/E는 37.6, 선행 P/E 20.7. 후행 이익수익률은 2.66%, 선행 이익수익률 4.84%. PEG 0.22 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $17.66.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 70/100 4/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | -7.1 | 0.44 | 3.75 | 3.43 | - |
| 2017 | -7.1 | 0.43 | 5.95 | 3.08 | - |
| 2018 | -20.2 | 0.64 | 5.84 | 5.06 | - |
| 2019 | -102.2 | 1.81 | 5.38 | 10.70 | - |
| 2020 | -74.6 | -0.52 | 6.19 | 22.18 | - |
| 2021 | -37.0 | -0.54 | 2.55 | 12.74 | - |
| 2022 | -46.4 | 0.86 | 1.58 | 5.73 | - |
| 2023 | -26.9 | -0.27 | 1.91 | 5.54 | - |
| 2024 | 125.5 | -0.96 | 2.58 | 6.79 | - |
| 2025 | 49.9 | 0.31 | 2.53 | 6.40 | - |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $-1.09 | $65.09M | $-31.36M | -48.2% |
| 2017 | $-0.91 | $71.95M | $-31M | -43.1% |
| 2018 | $-0.62 | $92.01M | $-23M | -25% |
| 2019 | $-0.36 | $120.37M | $-16.48M | -13.7% |
| 2020 | $-0.67 | $117.48M | $-35.85M | -30.5% |
| 2021 | $-1.11 | $219.51M | $-75.56M | -34.4% |
| 2022 | $-0.51 | $296.54M | $-36.56M | -12.3% |
| 2023 | $-1.02 | $361.05M | $-74.4M | -20.6% |
| 2024 | $0.30 | $445.76M | $24.14M | 5.4% |
| 2025 | $0.82 | $517.15M | $66.35M | 12.8% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $1.66 | $1.40 – $1.79 | $575.5M | $572.12M – $577.63M | 7 |
| 2027 | $1.79 | $1.50 – $1.93 | $646.7M | $634.44M – $654.13M | 7 |
| 2028 | $1.90 | $1.59 – $2.14 | $714.4M | $713.46M – $715.33M | 3 |
| 2029 | $2.03 | $1.99 – $2.06 | $782.28M | $770.53M – $791.53M | 1 |
| 2030 | $2.13 | $2.09 – $2.16 | $847.67M | $834.93M – $857.69M | 1 |
